These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19863452)

  • 1. Diagnostic performance of the (1-->3)-beta-D-glucan assay for invasive fungal disease.
    Koo S; Bryar JM; Page JH; Baden LR; Marty FM
    Clin Infect Dis; 2009 Dec; 49(11):1650-9. PubMed ID: 19863452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of invasive fungal disease using serum (1→3)-β-D-glucan: a bivariate meta-analysis.
    Lu Y; Chen YQ; Guo YL; Qin SM; Wu C; Wang K
    Intern Med; 2011; 50(22):2783-91. PubMed ID: 22082890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet parameters and (1, 3)-β-D-glucan as a diagnostic and prognostic marker of invasive fungal disease in preterm infants.
    Zhao D; Qiu G; Luo Z; Zhang Y
    PLoS One; 2015; 10(4):e0123907. PubMed ID: 25874376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease.
    Acosta J; Catalan M; del Palacio-Pérez-Medel A; Montejo JC; De-La-Cruz-Bértolo J; Moragues MD; Pontón J; Finkelman MA; del Palacio A
    Eur J Clin Microbiol Infect Dis; 2012 May; 31(5):721-31. PubMed ID: 21811868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of (1-->3)-beta-D-glucan in the diagnosis of invasive aspergillosis.
    Marty FM; Koo S
    Med Mycol; 2009; 47 Suppl 1():S233-40. PubMed ID: 18720216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.
    Ostrosky-Zeichner L; Alexander BD; Kett DH; Vazquez J; Pappas PG; Saeki F; Ketchum PA; Wingard J; Schiff R; Tamura H; Finkelman MA; Rex JH
    Clin Infect Dis; 2005 Sep; 41(5):654-9. PubMed ID: 16080087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of a combination of fungal biomarkers for the diagnosis of invasive fungal disease in high-risk haematology patients.
    Hammarström H; Stjärne Aspelund A; Christensson B; Heußel CP; Isaksson J; Kondori N; Larsson L; Markowicz P; Richter J; Wennerås C; Friman V
    Mycoses; 2018 Sep; 61(9):623-632. PubMed ID: 29577474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3).
    Lamoth F; Cruciani M; Mengoli C; Castagnola E; Lortholary O; Richardson M; Marchetti O;
    Clin Infect Dis; 2012 Mar; 54(5):633-43. PubMed ID: 22198786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia.
    Senn L; Robinson JO; Schmidt S; Knaup M; Asahi N; Satomura S; Matsuura S; Duvoisin B; Bille J; Calandra T; Marchetti O
    Clin Infect Dis; 2008 Mar; 46(6):878-85. PubMed ID: 18260755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usage of 1,3-β-D-Glucan for Early Detection of Invasive Mycoses and Outcome Parameter in Immunocompromised Critically Ill Patients.
    Lahmer T; Held J; Rasch S; Schnappauf C; Beitz A; Schmid RM; Huber W
    Mycopathologia; 2016 Dec; 181(11-12):815-821. PubMed ID: 27619810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].
    Rácil Z; Kocmanová I; Weinbergerová B; Winterová J; Lengerová M; Hrncírová K; Mayer J
    Klin Mikrobiol Infekc Lek; 2009 Apr; 15(2):48-57. PubMed ID: 19488961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of plasma (1, 3)-beta-D glucan assay for invasive fungal infections in patients with hematological disorders].
    Liu F; Wu T; Cai P; Liu Y; Lu Y; Zhou JR; Yang F; Liu Q; Gao YQ; Luo RM; Zhang JP; Sun Y; Cao XY; Yin YM; Zhao YL; Wang JB; Tong CR; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):1043-6. PubMed ID: 19698256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The (1,3){beta}-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation.
    Alexander BD; Smith PB; Davis RD; Perfect JR; Reller LB
    J Clin Microbiol; 2010 Nov; 48(11):4083-8. PubMed ID: 20720025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to interpret serum levels of beta-glucan for the diagnosis of invasive fungal infections in adult high-risk hematology patients: optimal cut-off levels and confounding factors.
    Hammarström H; Kondori N; Friman V; Wennerås C
    Eur J Clin Microbiol Infect Dis; 2015 May; 34(5):917-25. PubMed ID: 25573536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective Evaluation of the Fungitell® (1→3) Beta-D-Glucan Assay as a Diagnostic Tool for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplantation: A Report from the Children's Oncology Group.
    Otto WR; Dvorak CC; Boge CLK; Ostrosky-Zeichner L; Esbenshade AJ; Nieder ML; Alexander S; Steinbach WJ; Dang H; Villaluna D; Chen L; Skeens M; Zaoutis TE; Sung L; Fisher BT
    Pediatr Transplant; 2023 Feb; 27(1):e14399. PubMed ID: 36299233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia.
    White PL; Price JS; Posso RB; Barnes RA
    Med Mycol; 2017 Nov; 55(8):843-850. PubMed ID: 28340117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of the 1,3-β-D-glucan test for pneumocystis pneumonia in a tertiary university hospital in Denmark: A retrospective study.
    Engsbro AL; Najat S; Jørgensen KM; Kurtzhals JAL; Arendrup MC
    Med Mycol; 2019 Aug; 57(6):710-717. PubMed ID: 30535059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective Evaluation of Serum β-Glucan Testing in Patients With Probable or Proven Fungal Diseases.
    Angebault C; Lanternier F; Dalle F; Schrimpf C; Roupie AL; Dupuis A; Agathine A; Scemla A; Paubelle E; Caillot D; Neven B; Frange P; Suarez F; d'Enfert C; Lortholary O; Bougnoux ME
    Open Forum Infect Dis; 2016 Sep; 3(3):ofw128. PubMed ID: 27419189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspergillus PCR-based investigation of fresh tissue and effusion samples in patients with suspected invasive Aspergillosis enhances diagnostic capabilities.
    Reinwald M; Spiess B; Heinz WJ; Heussel CP; Bertz H; Cornely OA; Hahn J; Lehrnbecher T; Kiehl M; Laws HJ; Wolf HH; Schwerdtfeger R; Schultheis B; Burchardt A; Klein M; Dürken M; Claus B; Schlegel F; Hummel M; Hofmann WK; Buchheidt D
    J Clin Microbiol; 2013 Dec; 51(12):4178-85. PubMed ID: 24108612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introducing 1,3-beta-d-glucan for screening and diagnosis of invasive fungal diseases in Australian high-risk haematology patients: is there a clinical benefit?
    Garnham K; Halliday CL; Rai NJ; Jayawardena M; Hasan T; Kok J; Nayyar V; Gottlieb DJ; Gilroy NM; Chen SC
    Intern Med J; 2022 Mar; 52(3):426-435. PubMed ID: 32896984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.